Caleres, Inc. is a long-standing company primarily involved in the design, sourcing, retail, and wholesale distribution of various footwear products. Its operations span the United States, Canada, China, and Guam, organized into two main divisions: Famous Footwear and Brand Portfolio. The company's comprehensive product range includes athletic, casual, and dress footwear available under licensed, proprietary, and private-label brands, catering to women, men, and children. Through its numerous retail shoe stores, Caleres offers customers a wide selection of popular brand-name shoes from leading manufacturers like Nike, Skechers, adidas, and Dr. Martens. This is complemented by a substantial portfolio of company-owned and licensed brands such as Dr. Scholl's Shoes, Blowfish Malibu, LifeStride, Naturalizer, Franco Sarto, and Ryka. Beyond its physical storefronts, Caleres maintains a significant digital presence, managing a multitude of brand-specific e-commerce websites including naturalizer.com, samedelman.com, allenedmonds.com, and many others. The company also plays a crucial role in the broader footwear supply chain, engaging in the design, sourcing, manufacturing, and marketing of footwear to a diverse client base. This includes national chains, online retailers, department stores, mass merchandisers, independent retailers, and catalog businesses. Its wholesale division additionally distributes men's apparel, leather goods, and accessories under the Allen Edmonds brand, as well as specialized women's footwear lines such as LifeStride, Italian footwear by Franco Sarto, athletic shoes from Rykä, and collections from Vince, Bzees, Zodiac, Veronica Beard, and Via Spiga. With approximately 980 retail locations, the company has a strong market footprint. Founded in 1878 and formerly known as Brown Shoe Company, Inc., Caleres, Inc. is headquartered in St. Louis, Missouri.
Previous close
$12.43
−$0.02 · -0.16%
After-hours
$12.43
$0.00 · 0.00%
Oct 8, 4:01 PM ET
Regular session · ET · Market data may be delayed.
Caleres, Inc. is a long-standing company primarily involved in the design, sourcing, retail, and wholesale distribution of various footwear products. Its operations span the United States, Canada, China, and Guam, organized into two main divisions: Famous Footwear and Brand Portfolio. The company's comprehensive product range includes athletic, casual, and dress footwear available under licensed, proprietary, and private-label brands, catering to women, men, and children. Through its numerous retail shoe stores, Caleres offers customers a wide selection of popular brand-name shoes from leading manufacturers like Nike, Skechers, adidas, and Dr. Martens. This is complemented by a substantial portfolio of company-owned and licensed brands such as Dr. Scholl's Shoes, Blowfish Malibu, LifeStride, Naturalizer, Franco Sarto, and Ryka. Beyond its physical storefronts, Caleres maintains a significant digital presence, managing a multitude of brand-specific e-commerce websites including naturalizer.com, samedelman.com, allenedmonds.com, and many others. The company also plays a crucial role in the broader footwear supply chain, engaging in the design, sourcing, manufacturing, and marketing of footwear to a diverse client base. This includes national chains, online retailers, department stores, mass merchandisers, independent retailers, and catalog businesses. Its wholesale division additionally distributes men's apparel, leather goods, and accessories under the Allen Edmonds brand, as well as specialized women's footwear lines such as LifeStride, Italian footwear by Franco Sarto, athletic shoes from Rykä, and collections from Vince, Bzees, Zodiac, Veronica Beard, and Via Spiga. With approximately 980 retail locations, the company has a strong market footprint. Founded in 1878 and formerly known as Brown Shoe Company, Inc., Caleres, Inc. is headquartered in St. Louis, Missouri.
Day range
Current $12.43
52-week range
Current $12.43
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
48
Fair Value
Sentiment
56
Mixed
Risk
55
Elevated Risk
Momentum
31
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Caleres, Inc. is a long-standing company primarily involved in the design, sourcing, retail, and wholesale distribution of various footwear products. Its operations span the United States, Canada, China, and Guam, organized into two main divisions: Famous Footwear and Brand Portfolio. The company's comprehensive product range includes athletic, casual, and dress footwear available under licensed, proprietary, and private-label brands, catering to women, men, and children. Through its numerous retail shoe stores, Caleres offers customers a wide selection of popular brand-name shoes from leading manufacturers like Nike, Skechers, adidas, and Dr. Martens. This is complemented by a substantial portfolio of company-owned and licensed brands such as Dr. Scholl's Shoes, Blowfish Malibu, LifeStride, Naturalizer, Franco Sarto, and Ryka. Beyond its physical storefronts, Caleres maintains a significant digital presence, managing a multitude of brand-specific e-commerce websites including naturalizer.com, samedelman.com, allenedmonds.com, and many others. The company also plays a crucial role in the broader footwear supply chain, engaging in the design, sourcing, manufacturing, and marketing of footwear to a diverse client base. This includes national chains, online retailers, department stores, mass merchandisers, independent retailers, and catalog businesses. Its wholesale division additionally distributes men's apparel, leather goods, and accessories under the Allen Edmonds brand, as well as specialized women's footwear lines such as LifeStride, Italian footwear by Franco Sarto, athletic shoes from Rykä, and collections from Vince, Bzees, Zodiac, Veronica Beard, and Via Spiga. With approximately 980 retail locations, the company has a strong market footprint. Founded in 1878 and formerly known as Brown Shoe Company, Inc., Caleres, Inc. is headquartered in St. Louis, Missouri.
Day range
Current $12.43
52-week range
Current $12.43
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.76B USD | 2.72B USD | 2.82B USD | 2.97B USD | 2.78B USD |
| Cost of goods sold | 1.57B USD | 1.5B USD | 1.55B USD | 1.68B USD | 1.55B USD |
| Gross profit | 1.18B USD | 1.22B USD | 1.26B USD | 1.28B USD | 1.23B USD |
| Selling, general, and administrative | 1.16B USD | 1.07B USD | 1.06B USD | 1.07B USD | 1.01B USD |
| Operating expenses | 1.16B USD | 1.07B USD | 1.06B USD | 1.07B USD | 1.02B USD |
| Interest expense | 18.46M USD | 13.96M USD | 19.34M USD | 14.26M USD | 30.93M USD |
| Depreciation and amortization | 64.58M USD | 56.43M USD | 53.28M USD | 49.01M USD | 52.33M USD |
| Operating income | 28.98M USD | 149.86M USD | 201.31M USD | 214.33M USD | 205.81M USD |
| Net income | −7.05M USD | 107.26M USD | 163.87M USD | 181.74M USD | 137.02M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Cash distributions grouped by calendar year; partial years are marked.
$0.28
2025 complete year0.0% since 2021
2026 partial: $0.21
$0.28
2,021
$0.28
2,022
$0.28
2,023
$0.28
2,024
$0.28
2,025
$0.21
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Sep 11, 2026 | $0.07Quarterly | Sep 11, 2026 | Sep 25, 2026 |
Dividend | Jun 11, 2026 | $0.07Quarterly | Jun 11, 2026 | Jun 26, 2026 |
Dividend | Mar 26, 2026 | $0.07Quarterly | Mar 26, 2026 | Apr 10, 2026 |
Dividend | Dec 26, 2025 | $0.07Quarterly | Dec 26, 2025 | Jan 9, 2026 |
Dividend | Sep 12, 2025 | $0.07Quarterly | Sep 12, 2025 | Sep 26, 2025 |
Dividend | Jun 5, 2025 | $0.07Quarterly | Jun 5, 2025 | Jun 20, 2025 |
Ex-dividend Sep 11, 2026
$0.07
Quarterly
Record Sep 11, 2026 · Payment Sep 25, 2026
Ex-dividend Jun 11, 2026
$0.07
Quarterly
Record Jun 11, 2026 · Payment Jun 26, 2026
Ex-dividend Mar 26, 2026
$0.07
Quarterly
Record Mar 26, 2026 · Payment Apr 10, 2026
Ex-dividend Dec 26, 2025
$0.07
Quarterly
Record Dec 26, 2025 · Payment Jan 9, 2026
Ex-dividend Sep 12, 2025
$0.07
Quarterly
Record Sep 12, 2025 · Payment Sep 26, 2025
Ex-dividend Jun 5, 2025
$0.07
Quarterly
Record Jun 5, 2025 · Payment Jun 20, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
Avantis U.S. Small Cap Value ETFAVUV15.43M0.05%30.54B USD0.25%$120.13+0.84%
Vanguard Morningstar Total Stock Market ETFVTI12.34M0.00%2.3T USD0.03%$379.56-0.39%
iShares Russell 2000 ETFIWM11.1M0.01%77.7B USD0.19%$277.57-0.05%
Schwab Fundamental U.S. Small Company Index ETFFNDA5.08M0.06%8.72B USD0.25%$35.56+0.45%
Vanguard Extended Market ETFVXF4.81M0.00%95.4B USD0.05%$233.13-0.15%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV4.69M0.02%26.69B USD0.33%$38.10+0.82%
State Street SPDR S&P Retail ETFXRT3.86M0.96%389.66M USD0.35%$83.91+1.21%
Dimensional - US Targeted Value ETFDFAT3.81M0.01%30B USD0.33%$67.56+0.72%
Avantis U.S. Small Cap Value ETFAVUV
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Schwab Fundamental U.S. Small Company Index ETFFNDA
Vanguard Extended Market ETFVXF
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
State Street SPDR S&P Retail ETFXRT
Dimensional - US Targeted Value ETFDFATAI-generated and delayed market data for informational and educational purposes only. Not investment advice.